MARIE LEAR: Open Payments
NPI 1114388501 · POMEROY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,293 in 82 payments from 21 companies in 2025. Trend: 2023 $553 · 2024 $1,016 · 2025 $1,293
Food & beverage: $1,293
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $465 |
| AstraZeneca Pharmaceuticals LP | 7 | $159 |
| Novo Nordisk Inc | 10 | $138 |
| Lilly USA, LLC | 12 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $47 |
| Insulet Corporation | 2 | $37 |
| Dexcom, Inc. | 1 | $22 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
Products named: QULIPTA, VRAYLAR, MOUNJARO, BREZTRI, UBRELVY, Kerendia, LINZESS, JARDIANCE.
Industry payments across OH — which companies pay providers there.
